Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: An international multicenter study

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 243-252

  Mahler, Michael ^a   Radice, Antonella ^b   Sinico, Renato A ^b   Damoiseaux, Jan ^c   Seaman, Andrea ^a   Buckmelter, Kristen ^a   Vizjak, Alenka ^d   Buchner, Carol ^a   Binder, Walter L ^a   Fritzler, Marvin J ^e   Cui, Zhao ^f  

^a INOVA DIAGNOSTICS INC   (United States)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

^e UNIVERSITY OF CALGARY   (Canada)

^f PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

autoantibodies; GBM; Goodpasture's syndrome; rapidly progressive crescentic glomerulonephritis (RPGN)

Indexed keywords

ANTIGEN; AUTOANTIBODY; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA 3 SUBUNIT; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GLOMERULUS BASEMENT MEMBRANE ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; AREA UNDER THE CURVE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EMBRYO; FEMALE; GOODPASTURE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; PLASMAPHERESIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; CASE-CONTROL STUDIES; COLLAGEN TYPE IV; GLOMERULAR BASEMENT MEMBRANE; HUMANS; IMMUNOASSAY; INTERNATIONAL AGENCIES; LUMINESCENT MEASUREMENTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84856631984     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr203     Document Type: Article

References (46)

1. Salama AD, Levy JB. Tolerance and autoimmunity in anti-GBM disease. J Am Soc Nephrol 2003; 14: 2988-2989 (Pubitemid 37305664)
2. Pedchenko V, Bondar O, Fogo AB et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010; 363: 343-354
3. Segelmark M, Hellmark T. Autoimmune kidney diseases. Autoimmun Rev 2010; 9: A366-A371
4. Levy JB, Turner AN, Rees AJ et al. Long-term outcome of anti-glomer-ular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001; 134: 1033-1042 (Pubitemid 32488657)
5. Abi-Fadel F, Desai NR, Vatandoust G et al. Monoclonal gammopathy of undetermined significance with amyloid deposition in the lung and non-amyloid eosinophilic deposition in the brain: a case report. Case Report Med 2010; 2010: 406102
6. Lockwood CM, Rees AJ, Pearson TA et al. Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet 1976; 1: 711-715
7. Saus J, Wieslander J, Langeveld JP et al. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 1988; 263: 13374-13380
8. Sinico RA, Radice A, Corace C et al. Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays. Nephrol Dial Transplant 2006; 21: 397-401 (Pubitemid 43159994)
9. O'Donoghue DJ, Short CD, Brenchley PE et al. Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease. Clin Nephrol 1989; 32: 251-255 (Pubitemid 20017365)
10. Weber MF, Andrassy K, Pullig O et al. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol 1992; 2: 1227-1234
11. Rutgers A, Slot M, Van PP et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 2005; 46: 253-262 (Pubitemid 41040353)
12. Rutgers A, Heeringa P, Damoiseaux JG et al. ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur J Intern Med 2003; 14: 287-295 (Pubitemid 37108722)
13. Hellmark T, Niles JL, Collins AB et al. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 1997; 8: 376-385 (Pubitemid 127454173)
14. Dougan T, Levy JB, Salama A et al. Characterization of autoanti-bodies from patients with Goodpasture's disease using a resonant mirror biosensor. Clin Exp Immunol 2002; 128: 555-561 (Pubitemid 34639320)
15. Levy JB, Hammad T, Coulthart A et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004; 66: 1535-1540 (Pubitemid 39298387)
16. Desai A, Goldschmidt RA, Kim GC. Sequential development of pulmonary renal syndrome associated with c-ANCA 3 years after development of anti-GBM glomerulonephritis. Nephrol Dial Transplant 2007; 22: 926-929 (Pubitemid 46351709)
17. Jayne DR, Marshall PD, Jones SJ et al. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990; 37: 965-970 (Pubitemid 20089230)
18. Szczech LA, Anderson A, Ramers C et al. The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease. Am J Kidney Dis 2006; 48: e55-e59 (Pubitemid 44425372)
19. Li CH, Li YC, Xu PS et al. Clinical significance of anti-glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis. Scand J Rheumatol 2006; 35: 201-208
20. Yang R, Cui Z, Hellmark T et al. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol 2007; 124: 207-212 (Pubitemid 47064520)
21. Zhao J, Yan Y, Cui Z et al. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity. Hum Immunol 2009; 70: 425-429
22. Segelmark M, Butkowski R, Wieslander J. Antigen restriction and IgG subclasses among anti-GBM autoantibodies. Nephrol Dial Transplant 1990; 5: 991-996
23. Andreoli SP, Yum MN, Bergstein JM. IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA. Am J Nephrol 1986; 6: 28-33 (Pubitemid 16190306)
24. Border WA, Baehler RW, Bhathena D et al. IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med 1979; 91: 21-25 (Pubitemid 9244628)
25. Cai G, Chen P, Wu D et al. IgA deposits along glomerular basement membranes in rapidly progressive glomerulonephritis. South Med J 2008; 101: 945-947
26. Gris P, Pirson Y, Hamels J et al. Antiglomerular basement membrane nephritis induced by IgA1 antibodies. Nephron 1991; 58: 418-424
27. Ho J, Gibson IW, Zacharias J et al. Antigenic heterogeneity of IgA anti-GBM disease: new renal targets of IgA autoantibodies. Am J Kidney Dis 2008; 52: 761-765
28. Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular- basement-membrane antibodies. Nephron Clin Pract 2003; 94: c59-c68
29. Zhao J, Cui Z, Yang R et al. Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity. Kidney Int 2009; 76: 1108-1115
30. Jaskowski TD, Martins TB, Litwin CM et al. Comparison of four enzyme immunoassays for the detection of immunoglobulin G antibody against glomerular basement membrane. J Clin Lab Anal 2002; 16: 143-145 (Pubitemid 34492366)
31. Bowman C, Lockwood CM. Clinical application of a radio-immunoassay for auto-antibodies to glomerular basement membrane. J Clin Lab Immunol 1985; 17: 197-202 (Pubitemid 16244239)
32. van Dorp R, Daha MR, Muizert Y et al. A rapid ELISA for measurement of anti-glomerular basement membrane antibodies using microwaves. J Clin Lab Immunol 1993; 40: 135-147
33. Xin G, Zhao M, Ding J et al. Purification of alpha chain NC1 domains of type IV collagen from bovine kidney and their application in ELISA for detecting anti-glomerular basement membrane antibodies. Beijing Da Xue Xue Bao 2003; 35: 494-498
34. Rutgers A, Damoiseaux J, Roozendaal C et al. ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J Clin Immunol 2004; 24: 435-440 (Pubitemid 39005576)
35. Damoiseaux J, Vaessen M, Knapen Y et al. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease. Ann N Y Acad Sci 2007; 1109: 454-463 (Pubitemid 47511388)
36. Kaul R, Johnson K, Scholz H et al. Performance of the BioPlex 2200 Autoimmune Vasculitis kit. Autoimmun Rev 2009; 8: 224-227
37. Mahler M, Fritzler MJ, Bluthner M. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies. Arthritis Res Ther 2005; 7: R19-R29
38. Westman KW, Bygren PG, Eilert I et al. Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant 1997; 12: 1863-1868 (Pubitemid 27379458)
39. Litwin CM, Mouritsen CL, Wilfahrt PA et al. Anti-glomerular basement membrane disease: role of enzyme-linked immunosorbent assays in diagnosis. Biochem Mol Med 1996; 59: 52-56 (Pubitemid 26346758)
40. Turner N, Mason PJ, Brown R et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 1992; 89: 592-601
41. Turner N, Forstova J, Rees A et al. Production and characterization of recombinant Goodpasture antigen in insect cells. J Biol Chem 1994; 269: 17141-17145 (Pubitemid 24204035)
42. Hellmark T, Brunmark C, Trojnar J et al. Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides. Clin Exp Immunol 1996; 105: 504-510 (Pubitemid 26297897)
43. Hellmann MA, Gerhardt TM, Rabe C et al. Goodpasture's syndrome with massive pulmonary haemorrhage in the absence of circulating anti-GBM antibodies? Nephrol Dial Transplant 2006; 21: 526-529 (Pubitemid 43160013)
44. Salama AD, Dougan T, Levy JB et al. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis 2002; 39: 1162-1167 (Pubitemid 34591930)
45. Chan EK, Fritzler MJ, Wiik A et al. AutoAbSC.Org-Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007; 6: 577-580
46. Schroeder HW Jr., Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol 2010; 125: S41-S52